Rabies is a deadly disease and endemic in over 100 countries. It causes around 59,000 human deaths annually, the vast majority in Asia and Africa. There are safe and effective human vaccines for pre- and post-exposure prophylaxis. With a prompt and proper post-exposure prophylaxis (PEP), exposed people have a survival rate close to 100%.
A recently published study conducted between 2011 and 2018 in China, and based on surveillance data in pigs, identified an emerging genotype 4 (G4) reassortant Eurasian avian-like (EA) A(H1N1) swine influenza virus that contains internal genes from the human A(H1N1)pdm09 and North American triple-reassortant (TR) lineage-derived internal genes.
European Immunization Week (EIW) is marked across the European Region every April. It aims to raise awareness of the importance of immunisation for people’s health and well-being. ECDC supports the European Immunization Week campaign lead by WHO/Europe by providing scientific evidence on immunisation.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 February 2020 and includes updates on cholera, Ebola virus disease, COVID-19 and seasonal influenza.
This guidance on community engagement for public health emergency preparedness is intended for public health authorities in EU/EEA Member States. It is meant to provide step-by-step technical support to Member States who are initiating or professionalising their core community engagement capacity. The guidance is organised according to the three core stages of the preparedness cycle: anticipation, response, and recovery.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 January 2020 and includes updates on Ebola virus disease, MERS, measles, influenza, polio and pnuemonia cases in China.